Yan-Ling Zhang (Yanling Zhang)

Publication Activity (10 Years)

Years Active: 2016-2022
Publications (10 Years): 5

Top Topics

Angiotensin Converting Enzyme

Wastewater Treatment

Diabetic Retinopathy

Top Venues

Evidence-based complementary and alternative medicine : eCAM

Oxidative medicine and cellular longevity

Journal of oncology

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Mengqi Huo, Sha Peng, Jing Li, Yan-Ling Zhang, Yanjiang Qiao
A Discovery Strategy for Active Compounds of Chinese Medicine Based on the Prediction Model of Compound-Disease Relationship. Journal of oncology 2022 (2022)
Yue Ren, Yanan Liu, Kaiyang Liu, Xiaoqian Huo, Chaoqun Liu, Yan-Ling Zhang
Discovery of Therapeutic Candidates for Diabetic Retinopathy Based on Molecular Switch Analysis: Application of a Systematic Process. Oxidative medicine and cellular longevity 2022 (2022)
Xiaoqian Huo, Fang Lu, Liansheng Qiao, Gongyu Li, Yan-Ling Zhang
A Component Formula of Chinese Medicine for Hypercholesterolemia Based on Virtual Screening and Biology Network. Evidence-based complementary and alternative medicine : eCAM 2018 (2018)
Xu Zhang, Fang Lu, Yan-Kun Chen, Gang-Gang Luo, Lu-di Jiang, Lian-Sheng Qiao, Yan-Ling Zhang, Yu-Hong Xiang
Discovery of Potential Orthosteric and Allosteric Antagonists of P2Y1R from Chinese Herbs by Molecular Simulation Methods. Evidence-based complementary and alternative medicine : eCAM 2016 (2016)
Gang-Gang Luo, Fang Lu, Liansheng Qiao, Xi Chen, Gongyu Li, Yan-Ling Zhang
Discovery of Potential Inhibitors of Aldosterone Synthase from Chinese Herbs Using Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Studies. BioMed research international 2016 (2016)